LongCovid
Preliminary data recently published by Nature suggests that taking antiviral ensitrelvir, which is not approved in the United States, shortens symptoms in people with mild COVID and might reduce risk of Long COVID — but more data are needed.
COVID pill is first to cut short positive-test time after infection (nature.com)
A new article published by Science Advances shows that SARS-CoV-2 infection induces fusion between neurons and between neurons and glia in mouse and also human brain organoids. The results of…
The Long COVID Initiative recently interviewed Ryan Prior, author of the “The Long Haul: Solving the Puzzle of the Pandemic’s Long Haulers and How they are Changing Healthcare Forever”.…
Breaking news! The Long COVID flyer is out now. Visit the Communication Material section on our website to find the brand-new flyer presenting the main objectives, the methodology, the…
The authors of this publication conducted a systematic review to determine the prevalence of persistent symptoms, functional disability, or pathological changes in adults or children at least 12…